International Trade Today is a service of Warren Communications News.
Subscriber Login
FDA
to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "forced labor").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD CBP).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., tariffs +Canada).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., FDA -alert).

Simplest form: Use the simplest form of a term (e.g. "metal" instead of "metals" or "entity list" instead of "entity listing" or "entity listed").

New and Revised FDA Import Alerts for June 18
June 20, 2025 |FDA

On June 18, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

New and Revised FDA Import Alerts for June 17
June 18, 2025 |FDA

On June 17, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:

FDA: Final Guidance Available on Post-Warning Letter Process for Drug Manufacturing Facilities
June 18, 2025 |FDA

The FDA says that final guidance is available on the implementation of the post-warning letter meeting process for certain drug manufacturing facilities, according to a Federal Register notice. Eligible facilities may request a post-warning letter meeting with the FDA on the facility's ongoing remediation efforts to address current good manufacturing practice deficiencies described in the warning letter.